Canada markets closed

IBEX Technologies Inc. (IBT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.30000.0000 (0.00%)
At close: 03:57PM EST
Full screen
Previous Close0.3000
Bid0.3100 x 0
Ask0.3300 x 0
Day's Range0.3000 - 0.3100
52 Week Range0.2200 - 0.4100
Avg. Volume11,158
Market Cap7.447M
Beta (5Y Monthly)0.15
PE Ratio (TTM)9.68
EPS (TTM)0.0310
Earnings DateDec. 07, 2021 - Dec. 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Simply Wall St.

    IBEX Technologies Inc.'s (CVE:IBT) Share Price Is Matching Sentiment Around Its Earnings

    IBEX Technologies Inc.'s ( CVE:IBT ) price-to-earnings (or "P/E") ratio of 10.8x might make it look like a buy right...

  • GlobeNewswire

    IBEX Reports Results for the Year Ended July 31, 2021

    MONTRÉAL, Québec, Nov. 11, 2021 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its financial results for the fiscal year ended July 31, 2021. “IBEX had another very good year, with EBITDA reaching a record level”, said Mr. Baehr, IBEX President & CEO. “The strong financial performance resulted from near-record revenues and a reduction in expenses, due mainly to the closure of the Iowa production facility. The increase in revenues was driven

  • GlobeNewswire

    IBEX Appoints Christine Charette to Board of Directors

    MONTRÉAL, June 28, 2021 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported that it has appointed Christine Charette to the IBEX Board of Directors. “We are extremely pleased to welcome Christine to our Board,” said Paul Baehr, IBEX Chairman and CEO. “Her wealth of experience in business development and business strategy in the biotech world will be of great value to IBEX.” Christine Charette is the Managing Partner & Founder of Scienta Advisors